Health Care : Life Sciences Tools & Services | Mid Cap Growth
Avantor, Inc. is a global provider of mission critical products and services. Its products include materials and consumables, equipment and instrumentation, and services and specialty procurement. Materials and consumables includes chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits and education and microbiology and clinical trial kits. Equipment and instrumentation includes filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets and critical environment supplies. Services and specialty procurement include onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services.
One of IBD's BOUT ETF breakout holdings
EPS % Chg (Last Qtr)106%
Joined IBD 50 06-09-21
Entry 32.89/ stop 30.63 1R 2.26
1R PRICE 35.15
2R PRICE 37.41
3R PRICE 39.67
Entering 1/2 position.
Just my own observations. Educational purposes and not financial advice. As always, do your own research.
Avantor, Inc. is a global provider of mission critical products and services. Its products include materials and consumables, equipment and instrumentation, and services and specialty procurement. Materials and consumables includes chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits and education and microbiology and clinical trial kits. Equipment and instrumentation includes filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets and critical environment supplies. Services and specialty procurement include onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services.
One of IBD's BOUT ETF breakout holdings
EPS % Chg (Last Qtr)106%
Joined IBD 50 06-09-21
Entry 32.89/ stop 30.63 1R 2.26
1R PRICE 35.15
2R PRICE 37.41
3R PRICE 39.67
Entering 1/2 position.
Just my own observations. Educational purposes and not financial advice. As always, do your own research.